Join AUScelerate’s BioGateway China: Shanghai and Suzhou Life Sciences Mission

China Life Sciences Ecosystem Immersion

Shanghai & Suzhou | 23-27 November 2026

AUScelerate’s BioGateway China: Ecosystem Immersion has been designed for Australian life sciences organisations seeking to better understand, engage with and build relationships within China’s rapidly evolving healthcare and innovation landscape.

Over five days, delegates will gain access to leading hospitals, innovation districts, biotech clusters, funders, government and industry leaders across Shanghai and Suzhou. Participants will meet the organisations shaping China’s future in clinical research, drug development, medical technology and healthcare innovation while exploring new opportunities for collaboration and growth.

This is a curated executive immersion designed to help participants understand how China’s innovation ecosystem works, how partnerships are formed, and where future opportunities may emerge for Australian organisations.

Why China?

China is no longer simply a manufacturing hub or an emerging healthcare market. It’s now one of the world’s most dynamic life sciences ecosystems, driving innovation in clinical research, biotechnology, medical technology and translational science at unprecedented speed.

This is a market with globally competitive capabilities in:

Clinical research and trial delivery
Biotechnology and drug development
Medical technology innovation
Digital health and AI-enabled healthcare
Research translation and commercialisation
Manufacturing and supply chain excellence

For Australian organisations, understanding China’s innovation ecosystem is increasingly important for identifying collaboration opportunities, supporting global growth strategies and building long-term relationships with partners across Asia.

Choose your Track

Track A: Ecosystem Immersion Designed for organisations seeking to understand China’s life sciences ecosystem, clinical research landscape and innovation environment.	Track B: Executive Partnering Designed for clinical trial associated organisations actively seeking partnerships, clients and commercial opportunities.
Ideal for: Exploring opportunities in China Understanding the clinical research landscape Building your market intelligence and strategic relationships Developing a future China engagement strategy	Ideal for: Strengthening existing China relationships Expanding your business development pipeline Meeting pre-qualified clients, collaborators and partners Advancing commercial discussions already underway
What you get: Gain direct access to leading hospitals, innovation precincts hosting hundreds of companies, research institutes and biotech clusters Relationships with key stakeholders across Shanghai and Suzhou Deeper understanding of how China’s life sciences ecosystem operates and where future collaboration opportunities may exist.	What you get: Everything in Track A Dedicated business development windows Priority access to curated pre-qualified partnering opportunities with Chinese organisations.

Track A: Ecosystem Immersion

Designed for organisations seeking to understand China’s life sciences ecosystem, clinical research landscape and innovation environment.

Track B: Executive Partnering

Designed for clinical trial associated organisations actively seeking partnerships, clients and commercial opportunities.

Ideal for:

Exploring opportunities in China
Understanding the clinical research landscape
Building your market intelligence and strategic relationships
Developing a future China engagement strategy

Ideal for:

Strengthening existing China relationships
Expanding your business development pipeline
Meeting pre-qualified clients, collaborators and partners
Advancing commercial discussions already underway

What you get:

Gain direct access to leading hospitals, innovation precincts hosting hundreds of companies, research institutes and biotech clusters
Relationships with key stakeholders across Shanghai and Suzhou
Deeper understanding of how China’s life sciences ecosystem operates and where future collaboration opportunities may exist.

What you get:

Everything in Track A
Dedicated business development windows
Priority access to curated pre-qualified partnering opportunities with Chinese organisations.

Who Should Attend?

This executive mission is designed for organisations operating across the life sciences sector, including:

Contract Research Organisations (CROs)
Contract Development and Manufacturing Organisations (CDMOs)
Biotech and medtech companies
Clinical trial and regulatory specialists
Commercialisation and market access advisors
Research institutes and innovation organisations
Business development and strategy leaders
Executives responsible for partnerships, growth and international expansion

Whether you’re exploring China for the first time or looking to deepen existing relationships, this mission offers a structured pathway to understand the market, build connections and uncover new opportunities.

Costs

Participation in AUScelerate’s BioGateway China: Immersion Mission is:

Track A: Ecosystem Immersion $2,500 (ex. GST)*
Track B: Executive Partnering $5,000 (ex. GST)*

This fee covers the first individual from your company; for every subsequent individual from the same company, please add $1000 (ex. GST).

*NB this fee includes all catering, ground transfer between venues and fare from Shanghai to Suzhou, but does not include international travel costs and travel to/from airports.

Important dates

Delegates should plan to arrive in Shanghai by Monday 23 November 2026 noon local time for the program to commence. The program will conclude after lunch on Friday 27 November 2026.
Registration closes Friday 16 October 2026 with places limited, so we encourage you to register soon.

For any queries, please contact Dr Michelle Lam (mission coordinator) or Jarrod Belcher (Director of Partnerships).

Join the Information Session Webinar

In this webinar, find out about more about AUScelerate’s five-day program, including the curated two-tracks program designed for companies wanting to explore targeted opportunities. This November delegation is being supported directly by our Shanghai partners, the Shanghai Center of Biomedicine Development, to ensure the visit is as impactful as possible.

You will hear from the AUScelerate team including, CEO and Managing Director Stuart Dignam and Program Lead, Michelle Lam and other guests. With time for Q&A.

When: Tuesday 22 September 2026, 4pm-5pm AEST

Where: Online